Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica (original) (raw)

• Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59, 499–505 (2002).
• Jacob, A. & Weinshenker, B. G. An approach to the diagnosis of acute transverse myelitis. Semin. Neurol. 28, 105–120 (2008).
  Article Google Scholar
• Frohman, E. M. & Wingerchuk, D. M. Clinical practice. Transverse myelitis. N. Engl. J. Med. 363, 564–572 (2010).
  Article CAS Google Scholar
• Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106–2112 (2004).
  Article CAS Google Scholar
• Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485–1489 (2006).
  Article CAS Google Scholar
• Bou-Haidar, P., Peduto, A. J. & Karunaratne, N. Differential diagnosis of T2 hyperintense spinal cord lesions: part A. J. Med. Imaging Radiat. Oncol. 52, 535–543 (2008).
  Article CAS Google Scholar
• Bou-Haidar, P., Peduto, A. J. & Karunaratne, N. Differential diagnosis of T2 hyperintense spinal cord lesions: part B. J. Med. Imaging Radiat. Oncol. 53, 152–159 (2009).
  Article CAS Google Scholar
• Do-Dai, D. D., Brooks, M. K., Goldkamp, A., Erbay, S. & Bhadelia, R. A. Magnetic resonance imaging of intramedullary spinal cord lesions: a pictorial review. Curr. Probl. Diagn. Radiol. 39, 160–185 (2010).
  Article Google Scholar
• Jarius, S. et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J. Neurol. Sci. 306, 82–90 (2011).
  Article CAS Google Scholar
• Pittock, S. J. et al. Brain abnormalities in neuromyelitis optica. Arch. Neurol. 63, 390–396 (2006).
  Article Google Scholar
• Pittock, S. J. et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch. Neurol. 63, 964–968 (2006).
  Article Google Scholar
• Wingerchuk, D. M. Diagnosis and treatment of neuromyelitis optica. Neurologist 13, 2–11 (2007).
  Article Google Scholar
• Cassinotto, C. et al. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J. Neuroradiol. 36, 199–205 (2009).
  Article CAS Google Scholar
• Weinshenker, B. G. et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 59, 566–569 (2006).
  Article CAS Google Scholar
• Matiello, M. et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70, 2197–2200 (2008).
  Article CAS Google Scholar
• McKeon, A. et al. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39, 87–90 (2009).
  Article Google Scholar
• Wandinger, K. P. et al. Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome. Arthritis Rheum. 62, 1198–1200 (2010).
  Article CAS Google Scholar
• Vitali, C. et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554–558 (2002).
  Article CAS Google Scholar
• Delalande, S. et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 83, 280–291 (2004).
  Article Google Scholar
• Bertsias, G. K. et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann. Rheum. Dis. 69, 2074–2082 (2010).
  Article CAS Google Scholar
• Luyendijk, J. et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum. 63, 722–732 (2011).
  Article CAS Google Scholar
• Schulz, S. W. et al. Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases. Rheumatol. Int. http://dx.doi.org/10.1007/s00296-011-2053-1.
• Heinlein, A. C. & Gertner, E. Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus 16, 823–826 (2007).
  Article CAS Google Scholar
• Mornas, A. R., Thomas, T., Pallot, P. B., Chopin, F. & Raoux, D. Longitudinal myelitis in a patient with systemic lupus erythematosus. Joint Bone Spine 77, 181–183 (2010).
  Article Google Scholar
• Costabel, U. Sarcoidosis: clinical update. Eur. Respir. J. Suppl. 32, 56s–68s (2001).
  CAS PubMed Google Scholar
• Stern, B. J., Krumholz, A., Johns, C., Scott, P. & Nissim, J. Sarcoidosis and its neurological manifestations. Arch. Neurol. 42, 909–917 (1985).
  Article CAS Google Scholar
• Bolat, S., Berding, G., Dengler, R., Stangel, M. & Trebst, C. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J. Neurol. Sci. 287, 257–259 (2009).
  Article CAS Google Scholar
• Calamia, K. T. & Kaklamanis, P. G. Behçet's disease: recent advances in early diagnosis and effective treatment. Curr. Rheumatol. Rep. 10, 349–355 (2008).
  Article CAS Google Scholar
• [No authors listed] Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 335, 1078–1080 (1990).
• Akman-Demir, G., Serdaroglu, P. & Tasci, B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain 122, 2171–2182 (1999).
  Article Google Scholar
• Fukae, J. et al. Subacute longitudinal myelitis associated with Behçet's disease. Intern. Med. 49, 343–347 (2010).
  Article Google Scholar
• Yesilot, N. et al. Clinical characteristics and course of spinal cord involvement in Behçet's disease. Eur. J. Neurol. 14, 729–737 (2007).
  Article CAS Google Scholar
• Tartaglino, L. M. et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195, 725–732 (1995).
  Article CAS Google Scholar
• Qiu, W. et al. Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database. J. Neurol. Neurosurg. Psychiatry 81, 209–212 (2010).
  Article CAS Google Scholar
• Jarius, S. et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 79, 1134–1136 (2008).
  Article CAS Google Scholar
• Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: revisions to the McDonald criteria. Ann. Neurol. 69, 292–302 (2011) (2010).
  Article Google Scholar
• Banwell, B. et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 70, 344–352 (2008).
  Article CAS Google Scholar
• Young, N. P., Weinshenker, B. G. & Lucchinetti, C. F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 28, 84–94 (2008).
  Article Google Scholar
• Berger, J. R. & Sabet, A. Infectious myelopathies. Semin. Neurol. 22, 133–142 (2002).
  Article Google Scholar
• Sellner, J., Hemmer, B. & Muhlau, M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J. Autoimmun. 34, 371–379 (2010).
  Article CAS Google Scholar
• Umehara, F. et al. Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy. J. Neurovirol. 13, 260–267 (2007).
  Article Google Scholar
• Delgado, S. R., Sheremata, W. A., Brown, A. D. & McCarthy, M. Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports. J. Neurovirol. 16, 249–253 (2010).
  Article Google Scholar
• Meurs, L., Labeye, D., Declercq, I., Pieret, F. & Gille, M. Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. Eur. Neurol. 52, 186–188 (2004).
  Article Google Scholar
• Chilver-Stainer, L., Fischer, U., Hauf, M., Fux, C. A. & Sturzenegger, M. Syphilitic myelitis: rare, nonspecific, but treatable. Neurology 72, 673–675 (2009).
  Article CAS Google Scholar
• Kikuchi, S., Shinpo, K., Niino, M. & Tashiro, K. Subacute syphilitic meningomyelitis with characteristic spinal MRI findings. J. Neurol. 250, 106–107 (2003).
  Article Google Scholar
• Saleem, S., Belal, A. I. & el Ghandour, N. M. Spinal cord schistosomiasis: MR imaging appearance with surgical and pathologic correlation. AJNR Am. J. Neuroradiol. 26, 1646–1654 (2005).
  PubMed Google Scholar
• Seo, H. S. et al. Nonenhancing intramedullary astrocytomas and other MR imaging features: a retrospective study and systematic review. AJNR Am. J. Neuroradiol. 31, 498–503 (2010).
  Article CAS Google Scholar
• Flanagan, E. P. et al. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 76, 2089–2095 (2011).
  Article CAS Google Scholar
• Ducray, F. et al. Devic's syndrome-like phenotype associated with thymoma and anti-CV2/CRMP5 antibodies. J. Neurol. Neurosurg. Psychiatry 78, 325–327 (2007).
  Article Google Scholar
• Graus, F. et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 75, 1135–1140 (2004).
  Article CAS Google Scholar
• Pittock, S. J. & Lucchinetti, C. F. Inflammatory transverse myelitis: evolving concepts. Curr. Opin. Neurol. 19, 362–368 (2006).
  Article Google Scholar
• Pittock, S. J. et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann. Neurol. 58, 96–107 (2005).
  Article Google Scholar
• Pittock, S. J. et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin. Proc. 81, 1207–1214 (2006).
  Article CAS Google Scholar
• Titulaer, M. J. et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur. J. Neurol. 18, 19-e3 (2011).
  Article Google Scholar
• Krampla, W. et al. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur. Radiol. 19, 2535–2543 (2009).
  Article Google Scholar
• Mateen, F. J., Monrad, P. A., Hunderfund, A. N., Robertson, C. E. & Sorenson, E. J. Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes. Eur. J. Neurol. 18, 218–225 (2011).
  Article CAS Google Scholar
• Krings, T., Mull, M., Gilsbach, J. M. & Thron, A. Spinal vascular malformations. Eur. Radiol. 15, 267–278 (2005).
  Article Google Scholar
• Mull, M. et al. Value and limitations of contrast-enhanced MR angiography in spinal arteriovenous malformations and dural arteriovenous fistulas. AJNR Am. J. Neuroradiol. 28, 1249–1258 (2007).
  Article CAS Google Scholar
• Misra, U. K., Kalita, J. & Das, A. Vitamin B12 deficiency neurological syndromes: a clinical, MRI and electrodiagnostic study. Electromyogr. Clin. Neurophysiol. 43, 57–64 (2003).
  CAS PubMed Google Scholar
• Goodman, B. P., Chong, B. W., Patel, A. C., Fletcher, G. P. & Smith, B. E. Copper deficiency myeloneuropathy resembling B12 deficiency: partial resolution of MR imaging findings with copper supplementation. AJNR Am. J. Neuroradiol. 27, 2112–2114 (2006).
  CAS PubMed Google Scholar
• Jaiser, S. R. & Winston, G. P. Copper deficiency myelopathy. J. Neurol. 257, 869–881 (2010).
  Article CAS Google Scholar
• McKeon, A. et al. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch. Neurol. 66, 1134–1138 (2009).
  PubMed Google Scholar
• Wang, K. C., Wang, S. J., Lee, C. L., Chen, S. Y. & Tsai, C. P. The rescue effect of plasma exchange for neuromyelitis optica. J. Clin. Neurosci. 18, 43–46 (2011).
  Article CAS Google Scholar
• Sellner, J. et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur. J. Neurol. 17, 1019–1032 (2010).
  Article CAS Google Scholar
• Trebst, C. et al. Diagnosis and treatment of neuromyelitis optica: consensus recommendations of the Neuromyelitis Optica Study Group. Nervenarzt 82, 768–777 (2011).
  Article CAS Google Scholar
• Taylor, J. K. & McMurray, R. V. Medical therapy for systemic lupus erythematosus. J. Miss. State Med. Assoc. 52, 39–43 (2011).
  PubMed Google Scholar
• Jounieaux, F. et al. Infliximab treatment for chronic sarcoidosis—a case series. Rev. Mal. Respir. 27, 685–692 (2010).
  Article CAS Google Scholar
• Vargas, D. L. & Stern, B. J. Neurosarcoidosis: diagnosis and management. Semin. Respir. Crit. Care Med. 31, 419–427 (2010).
  Article Google Scholar
• Chintamaneni, S., Patel, A. M., Pegram, S. B., Patel, H. & Roppelt, H. Dramatic response to infliximab in refractory neurosarcoidosis. Ann. Indian Acad. Neurol. 13, 207–210 (2010).
  Article Google Scholar
• Kikuchi, H., Aramaki, K. & Hirohata, S. Effect of infliximab in progressive neuro-Behçet's syndrome. J. Neurol. Sci. 272, 99–105 (2008).
  Article CAS Google Scholar
• Wiendl, H. et al. Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J. Neurol. 255, 1449–1463 (2008).
  Article CAS Google Scholar
• Polman, C. H. et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354, 899–910 (2006).
  Article CAS Google Scholar
• Kappos, L. et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387–401 (2010).
  Article CAS Google Scholar
• Bernaerts, A. et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur. Radiol. 13, 1876–1890 (2003).
  Article CAS Google Scholar